Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Katy A Lassahn"'
Autor:
Teresa M DesRochers, Danielle Nadeau, Katy A Lassahn, Ashley K Elrod, Natalie W Dance, Kimberly J Burgess, Aaron L Carlson, Melissa Millard, Michael J Wick, Kathryn M Appleton
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss Suppl 1 (2023)
Externí odkaz:
https://doaj.org/article/766d95c0b234474891756f460d0c7398
Autor:
Katy A. Lassahn, Ashley K. Elrod, Aaron L. Carlson, Natalie A. Dance, Melissa Millard, Michael J. Wick, Teresa M. DesRochers, Kathryn M. Appleton
Publikováno v:
Cancer Research. 83:2275-2275
Biological therapies for the treatment of cancer are utilized for the same ultimate purpose as chemically derived cancer drugs, to induce tumor cell death. However, the differing mechanisms of action often make the evaluation of biologic drug efficac
Publikováno v:
Cancer Research. 82:287-287
Cancer treatment has evolved with the advent of immunotherapies. This drug class now plays a key role in supplementing or even replacing chemotherapies as first line treatments. Immunotherapies such as immune checkpoint inhibitors, bispecific antibod
Publikováno v:
Cancer Research. 82:4162-4162
Agents that invoke an immune response against tumors, such as immune checkpoint inhibitors (ICIs), have revolutionized cancer treatment. Understanding the efficacy of these agents involves more than just the characterization of patient-specific tumor
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 8, Iss Suppl 3 (2020)
Background Immune checkpoint inhibitors (ICIs) have shifted the cancer treatment paradigm. Cancers such as melanoma and non-small cell lung cancer (NSCLC) demonstrate high tumor mutational burden and tumor neoantigen expression which renders them mor
Autor:
Teresa M. DesRochers, Stephen Shuford, Lillia Holmes, Ashley Elrod, Kathryn M. Appleton, Katy A. Lassahn
Publikováno v:
Cancer immunology, immunotherapy : CII. 70(3)
Immune checkpoint inhibitors (ICIs) that target programmed cell death protein 1 (PD-1) and programmed death-ligand 1 (PD-L1) have shown modest activity as monotherapies for the treatment of ovarian cancer (OC). The rationale for using these therapies
Publikováno v:
Cancer Research. 80:315-315
Three-dimensional (3D) culture of immortalized cell lines and patient-derived primary cells has been shown to be a more representative in vitro model of tumor biology compared to standard 2D techniques. For immune-oncology, animal models continue to
Autor:
Appleton, Kathryn M., Elrod, Ashley K., Lassahn, Katy A., Shuford, Stephen, Holmes, Lillia M., DesRochers, Teresa M.
Publikováno v:
Cancer Immunology, Immunotherapy; Mar2021, Vol. 70 Issue 3, p843-856, 14p